Drug
Dipyridamole
Dipyridamole: highest development phase Approved, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| PERSANTINE | Approved |
Latest
No recent events.
Follow Dipyridamole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.